Ending the current distribution model for pharmaceutical drug samples (PDS) would have a disproportionate impact on disadvantaged populations, researchers wrote in a letter in JAAD. Instead, they said ...
To defend the lousy quality control of Tesla cars, one of its advocates once wrote that the company sold prototypes, not production vehicles. While that is true regarding software – especially ...